Breaking News
August 21, 2018 - New badge course explores research around skeletal muscle as an endocrine organ
August 21, 2018 - TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
August 21, 2018 - Increased levels of human herpesvirus ID’d in Alzheimer’s
August 21, 2018 - To help patients quash pain, researcher develops practical guide for health care providers
August 20, 2018 - Medicine on the front line to be presented at Medical Innovation 2018
August 20, 2018 - Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody
August 20, 2018 - The man who sold America on vitamin D — and profited in the process
August 20, 2018 - Finding the light in antimicrobials
August 20, 2018 - Unique pain program helps surgical patients wean off opioids safely and effectively
August 20, 2018 - Strawberries could mitigate colonic inflammation
August 20, 2018 - FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters
August 20, 2018 - Using Facebook to help young adults quit smoking
August 20, 2018 - ‘Liquid biopsy’ predicts lymphoma therapy success within days | News Center
August 20, 2018 - 5 Questions with Jordan Orange, Chair of Pediatrics
August 20, 2018 - New assay may help improve both sarcoma diagnosis and treatment
August 20, 2018 - New class of insect repellents to fight against mosquito-borne diseases
August 20, 2018 - ACA Coverage Gains Include Workers Without Insurance
August 20, 2018 - 3-D printed biomaterials for bone tissue engineering
August 20, 2018 - Current surveillance system does not quickly pick up most listeriosis cases in the EU, study reveals
August 20, 2018 - Prenatal exposure to acute stress can affect cognitive function in children of low-income households
August 20, 2018 - New study examines scope of state policies targeting drug use by pregnant women
August 20, 2018 - Researchers find long-term structural, functional brain abnormalities in individuals with AUDs
August 20, 2018 - Shortage of insurance fraud cops sparks campaign debate
August 20, 2018 - Researchers find STAT3 as therapeutic target for chronic active EBV infection
August 20, 2018 - Health Tip: Keep Diabetic Feet Healthier
August 20, 2018 - FDA approves brain stimulation device for OCD
August 20, 2018 - NYU Langone’s Perlmutter Cancer Center expands Blood and Marrow Transplant Program
August 20, 2018 - New drug shows potential to prevent painful side effect of therapy
August 20, 2018 - RDMD raises $3 million in seed funding to accelerate rare disease research, drug development
August 20, 2018 - Illicit drug use is higher during celebratory events, may be worse than previously thought
August 20, 2018 - Exploring the relationship between fever and cancer incidence
August 20, 2018 - Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival
August 20, 2018 - Brain tumors trap immune cells needed to fight cancer in the bone marrow, finds research
August 20, 2018 - Three factors that contribute to physician burnout
August 20, 2018 - Babies dependent on opioids need touch, not tech
August 20, 2018 - Understanding How Antibodies Shape the Gut Microbiome
August 20, 2018 - Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of Korsuva (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus
August 20, 2018 - Kidney transplant chains more effective in saving lives
August 20, 2018 - Study unravels cellular and molecular mechanisms behind dermal condensate formation
August 20, 2018 - New integrated gene logic-chips could have great value in medical care
August 20, 2018 - FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
August 20, 2018 - Total, open repairs decline for abdominal aortic aneurysms
August 20, 2018 - Novel system can pinpoint ingestible implants inside the body using wireless signals
August 20, 2018 - Infection rates of high risk oral HPV in England found to be lower than expected
August 20, 2018 - Making robots as valuable and trustworthy assistants for medical therapies
August 20, 2018 - Patients with low-risk blood clots can be better treated at home than at hospital
August 20, 2018 - Passive smoking exposure among kids greatly increases COPD risk late in life
August 20, 2018 - Primary Care Provider Burnout Rate Low in Small Practices
August 20, 2018 - Discovery presents treatment hope for Alzheimer’s and other neurodegenerative diseases
August 20, 2018 - Stroke patients appear to receive better care at teaching hospitals with less chance of readmission
August 20, 2018 - Distinct origin of ADHD identified In children with history of traumatic brain injury
August 20, 2018 - AHA: Wildfire Smoke Threatens Health of Those Near and Far
August 20, 2018 - Here’s a mental health workout that’s as simple as ABC
August 20, 2018 - Newly discovered cytoskeleton utilized by cancer cells for survival
August 19, 2018 - Bifidobacteria supplement colonizes gut of breastfed infants
August 19, 2018 - Why patients with Alzheimer’s markers never develop the condition
August 19, 2018 - ACA’s Medicaid expansion associated with increase in prescriptions for opioid use disorder treatment
August 19, 2018 - Important factor may be missing in models used to predict spread of epidemics from climate change
August 19, 2018 - Indian-Americans have fewer sudden infant deaths, study finds
August 19, 2018 - Experts advise against universal genomic screening of newborns
August 19, 2018 - New trial to investigate whether weight loss before conception can make mom and baby healthier
August 19, 2018 - Sun Pharma Announces FDA Approval of Cequa (cyclosporine) Ophthalmic Solution to Treat Dry Eye Disease
August 19, 2018 - Researchers examining Parkinson’s resilience
August 19, 2018 - HPI, INTEGRIS and USPI enter into agreement to offer patients more choice, flexibility of care
August 19, 2018 - Researchers find mechanism that prepares brain to replicate repeated actions
August 19, 2018 - Those who are emotionally stable when young may remain the most stable as they age
August 19, 2018 - URI professor develops simpler and quicker method for detecting impurity in heparin
August 19, 2018 - Mayo Medical Laboratories and NDSC collaborate to develop new patient blood-management solution
August 19, 2018 - Insight into endocrine cancers and treatment options
August 19, 2018 - HPV Legislation Doesn’t Impact Teen Sexual Behaviors
August 19, 2018 - Exenatide treatment alleviated symptoms of depression in patients
August 19, 2018 - Tufts researchers win grant to study integration of genomic sequencing into neonatal care
August 19, 2018 - Novel finger-prick test can help prevent toxoplasmosis
August 19, 2018 - Cosmetic Procedures Boost Well-Being, Poll Shows
August 19, 2018 - Responsive parenting intervention results in lower BMIs through age three
August 19, 2018 - Anticancer drugs can help plants to battle infection
August 19, 2018 - Sunscreen from bathers releases significant quantities of polluting titanium dioxide into the sea
August 19, 2018 - Case Western Reserve gets three-year grant to enhance food systems in Cleveland neighborhoods
August 19, 2018 - Teenagers can thank their parents’ positive attitude for avoiding obesity
August 19, 2018 - Body mass index positively linked with blood pressure
New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips

New technique for identifying alcoholism puts treatment options at patients’ and providers’ fingertips

image_pdfDownload PDFimage_print
Credit: Virginia Commonwealth University

Ninety percent of adults in the U.S. with an Alcohol Use Disorder don’t get treatment, according to the National Institute on Alcohol Abuse and Alcoholism, part of the National Institutes of Health. To help make treatment more accessible, the NIH recently launched an online Alcohol Treatment Navigator, which gives providers and AUD patients information on evidence-based treatment options. The site also offers a brief survey to help a potential patient determine the range or severity of a problem.

Meeting patients where they are and then drawing them to the services that are most beneficial is the avenue by which more people will receive treatment and more AUD treatments will be developed, said Dace Svikis, Ph.D., a professor in the Virginia Commonwealth University Departments of Psychology and Psychiatry and the VCU Health Department of Obstetrics and Gynecology. Svikis is currently working on several projects researching the effects of alcohol, modernized treatments and appropriately diagnosing AUD.

VCU and VCU Health are home to several programs to help varying demographics cope with AUD, including the multidisciplinary Alcohol Research Center, which focuses on preclinical and clinical studies to identify the root cause of alcohol misuse and alcoholism. Tools such as the NIAAA’s Alcohol Treatment Navigator modernize how patients are treated and revolutionize how treatment is offered and administered, Svikis said.

VCU News recently talked with Svikis to learn how VCU and VCU Health are helping patients by making sure treatment is accessible to anyone in need.

How has alcoholism traditionally been diagnosed?

Traditionally, AUD, commonly referred to as alcoholism, is diagnosed when there is a problematic pattern of drinking that leads to clinically significant impairment or distress. To make a diagnosis, a trained clinician typically interviews the person about his or her drinking. The interviewer looks for evidence of several things:

  • Impaired control or drinking more than intended
  • Social impairment, such as conflicts with friends as a result of drinking or driving or operating machinery while inebriated
  • Physical impairment

In what way has alcoholism traditionally been treated?

Historically, alcoholism treatment was associated with either long-term residential treatment or Alcoholics Anonymous. Since that time, the menu of treatment options for AUD has expanded considerably. AUD treatment modalities range from inpatient medical detoxification to short- or long-term residential treatment, to various outpatient treatment options. Evidence-based behavioral treatments for AUD include brief intervention, typically delivered in medical care settings like an emergency department, as well as cognitive behavioral therapy, motivational enhancement therapy, contingency management and behavioral couples and family counseling among others. While less well-known, there are also three Food and Drug Administration-approved nonaddictive medications for AUD: naltrexone, acamprosate and disulfiram.

In your professional opinion, how potentially useful is a tool like the Alcohol Treatment Navigator?

It is often challenging for individuals with AUD to obtain accurate information about alcohol treatment options and different paths to recovery. The Alcohol Treatment Navigator provides easy-to-understand information about AUD as a chronic, relapsing disorder and the range of well-researched alcohol treatment options to consider. This tool also makes it easier to search for local treatment options and other recovery resources, with a toolkit of downloadable worksheets to guide individuals in their search for appropriate, quality care. In addition, this tool provides information and support resources to people living with AUD and their family members.

How can addiction and treatment professionals use this type of tool to benefit patients?

Across a variety of settings, the Alcohol Treatment Navigator is something health care providers can make available to patients who report alcohol problems and are looking for the best local treatment options. It also can educate interested professionals about AUD and increase awareness about the range of evidence-based treatment options that exist in this country.

What recent studies has VCU been part of regarding the treatment of alcoholism?

VCU is involved in a variety of projects focused on the identification and treatment of heavy and problem drinking. One longstanding commitment is to community-based research through the National Institute on Drug Abuse Clinical Trials Network. In collaboration with Johns Hopkins University and Friends Research Institute, VCU represents the Mid-Atlantic branch of CTN.

Over the last 15 years, VCU researchers have contributed to several multi-site national studies of interventions such as motivational interviewing, medication-assisted treatment, and even an employment-focused intervention to improve outcomes in treatment. More recently, Lauretta Cathers, Ph.D., a faculty member in the Department of Rehabilitation Counseling in the School of Allied Health Professions, and I participated in a multi-site CTN study of the Tobacco, Alcohol, Prescription medication, and other Substance use measure—TAPS. The purpose of the study was to develop and test TAPS as a tool that could address the need for a brief screening and assessment instrument that would not only include all commonly used substances, but also could be implemented in routine clinical practice.

Is diagnosing alcoholism on a full spectrum a new concept or something you’ve recognized throughout your career?

Early in my career, I was taught that physical dependence on alcohol was an important factor in determining alcoholism severity. Particularly, it was important to assess the need for hospitalization, with medical management of the detoxification process. Subsequently, two diagnostic options were made available, with alcohol abuse generally considered less severe than alcohol dependence.

There is now a single diagnostic category, Alcohol Use Disorder, with several symptoms determining severity for any given individual. This single continuum and the labelling of severity by number of symptoms will likely make it a more salient variable in both clinical care and future research. At least two symptoms must be present to make a diagnosis, whereby more symptoms indicate greater severity. Symptom severity ranges from mild, two to three symptoms, to moderate, four to five symptoms. More than six symptoms indicates a severe problem.

What specific programs are in place at VCU (including referral programs) to treat and counsel people and families battling Alcohol Use Disorder?

Within VCU Health, hospitalized patients with AUD receive consultative services that include assessment, brief intervention and, when appropriate, referral to treatment. Many outpatient clinics at VCU routinely screen their patients to identify those at risk for problem drinking. Those identified, or who self-disclose an alcohol problem, also receive information about local treatment resources. Community Services Boards offer outpatient alcohol and other drug abuse treatment as well as mental health counseling and services. In the Richmond community, they include Richmond Behavioral Health Authority, Chesterfield Mental Health Support Services and Henrico Area Mental Health & Developmental Services.

VCU Health also has an outpatient facility, the MOTIVATE Clinic, established, in part, in response to the opioid epidemic. Many individuals who abuse opioids have comorbid conditions, including alcoholism, which is why this type of treatment is critical. For students, The Wellness Resource Center – The Well— is available. The Well offers a variety of individual- and peer-focused educational programs on early intervention for alcohol and other substance use disorders. Particularly noteworthy is our RAMS in Recovery program, which is a nationally recognized, confidential, community-based resource for students in recovery from alcohol and other drugs. Also, through the College Behavioral and Emotional Health Institute and Spit for Science, we have a universitywide program focused on the study of alcohol, and other drug use, and emotional health outcomes in college populations.


Explore further:
APA releases new practice guideline on treatment of alcohol use disorder

Provided by:
Virginia Commonwealth University

About author

Related Articles